Danish Health Authority awaits Danish study results before giving verdict on Astrazeneca

The EMA's Astrazeneca-related announcement will not influence the Danish pause of Astrazeneca vaccines.
Danish Health Authority Director General Søren Brostrøm | Photo: Jens Dresling/Ritzau Scanpix
Danish Health Authority Director General Søren Brostrøm | Photo: Jens Dresling/Ritzau Scanpix
BY RITZAU, TRANSLATED BY NIELSINE NIELSEN

The Danish Health Authority intends to wait until the Danish investigation of the Astrazeneca vaccine and possibly related rare cases of blood clots has been concluded before deciding whether Denmark will go back to using this particular vaccine, according to a press statement from the Danish Health Authority.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading